Cargando…
HIV-1 matrix protein p17 and its variants promote human triple negative breast cancer cell aggressiveness
BACKGROUND: The introduction of cART has changed the morbidity and mortality patterns affecting HIV-infected (HIV(+)) individuals. The risk of breast cancer in HIV(+) patients has now approached the general population risk. However, breast cancer has a more aggressive clinical course and poorer outc...
Autores principales: | Caccuri, Francesca, Giordano, Francesca, Barone, Ines, Mazzuca, Pietro, Giagulli, Cinzia, Andò, Sebastiano, Caruso, Arnaldo, Marsico, Stefania |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613317/ https://www.ncbi.nlm.nih.gov/pubmed/29021819 http://dx.doi.org/10.1186/s13027-017-0160-7 |
Ejemplares similares
-
Opposite Effects of HIV-1 p17 Variants on PTEN Activation and Cell Growth in B Cells
por: Giagulli, Cinzia, et al.
Publicado: (2011) -
Role of Autophagy in Von Willebrand Factor Secretion by Endothelial Cells and in the In Vivo Thrombin-Antithrombin Complex Formation Promoted by the HIV-1 Matrix Protein p17
por: Bugatti, Antonella, et al.
Publicado: (2020) -
The Synthetic Dipeptide Pidotimod Shows a Chemokine-Like Activity through CXC Chemokine Receptor 3 (CXCR3)
por: Caccuri, Francesca, et al.
Publicado: (2019) -
Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study
por: Caruso, Arnaldo, et al.
Publicado: (2014) -
Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17
por: Caccuri, Francesca, et al.
Publicado: (2016)